Hematide, a novel peptide-based erythropoiesis-stimulating agent for the treatment of anemia
{{output}}
Hematide is a synthetic peptide-based erythropoiesis-stimulating agent that is being developed by Affymax Inc and Takeda Pharmaceutical Co Ltd. Hematide is undergoing phase III clinical trials for anemia. ... ...
